Overview

This trial is active, not recruiting.

Condition parkinson disease
Treatment virtual care visit
Sponsor University of Rochester
Collaborator The Davis Phinney Foundation for Parkinson's
Start date March 2014
End date August 2016
Trial size 287 participants
Trial identifier NCT02144220, RSRB-50627

Summary

The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are:

1. To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally;

2. To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and

3. To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose health services research
Arm
(Experimental)
One-time virtual care visit for Parkinson disease.
virtual care visit Telemedicine visit
Video-conferencing visit with a Parkinson disease specialist

Primary Outcomes

Measure
Feasibility
time frame: 6 months
Impact
time frame: 6 months
Acceptability
time frame: 6 months

Secondary Outcomes

Measure
Feasibility (Descriptive)
time frame: 6 months
Impact of recommendations
time frame: 6 months

Eligibility Criteria

Male or female participants from 30 years up to 120 years old.

Inclusion Criteria: - Age greater than 30 - Self reported diagnosis of idiopathic Parkinson disease - Ability to converse in English - Ability and willingness to provide informed consent and complete study requirements - Access to a non-public computer or similar devices with broadband internet. - Located in New York, Maryland, Delaware, California, or Florida at time of virtual visit (or veterans with Parkinson disease anywhere in the U.S.) Exclusion Criteria: - Any condition (e.g.prominent psychosis) that in the investigator's or coordinator's judgment would preclude participation. - Concurrent enrollment in another telemedicine study.

Additional Information

Official title Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease
Principal investigator E. Ray Dorsey, MD, MBA
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by University of Rochester.